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By site-directed mutagenesis, Cys-I 16 was converted to Ser-116 in p-hydroxybenzoate hydroxylase (EC 1.14.13.2) from PseudomonusJIuorescens. 
In contrast to wild-type enzyme, the Cl 16s mutant is no longer susceptible to oxidation by hydrogen peroxide and shows no reactivity towards 
5,5’-dithiobis(2-nitrobenzoate). Crystals of the Cl 16s mutant are isomorphous with the crystal form of wild-type enzyme. A difference lectron 
density confirms the mutation made. 
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1. INTRODUCTION 
Microheterogeneity of purified enzymes is a common 
and often puzzling problem when studying the physical 
or catalytical properties of these proteins in detail. 
Microheterogeneity may occur in varying degrees 
depending on the purification and the actual state of the 
enzyme [ 11. 
For p-hydroxybenzoate hydroxylase from Pseudo- 
monas fluorescens it was shown that during purifica- 
tion Cys-116, located near the enzyme surface, is slowly 
oxidized in air. This leads to a variety of oxidation pro- 
ducts with normal catalytic properties [2]. Oxidation of 
Cys-116 however strongly hampers the crystallization 
of the enzyme [3]. 
p-Hydroxybenzoate hydroxylase from P. fruorescens 
is a homodimer with an apparent M, of about 89000, 
each subunit containing a non-covalently bound FAD 
molecule [4]. The reaction pathway has been establish- 
ed in detail [5] and crystallographic studies have 
resulted in high resolution three-dimensional models of 
the enzyme-substrate and enzyme-product complexes 
[6]. Fundamental features such as, e.g. the exact 
mechanism of hydroxylation [7,8] or the binding mode 
of NADPH [9] are still unclear. 
Recently, the genes encoding p-hydroxybenzoate 
hydroxylase from both P. aeruginosa [lo] and P. 
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fluorescens [l l] have been cloned in Escherichia coli. 
This now allows modification of the enzymes by site- 
directed mutagenesis. We describe here the effects of 
replacing Cys-116 in the P. fluorescens enzyme with a 
serine residue, thereby creating a mutant protein, which 
is expected to show resistance against this type of 
microheterogeneity. 
2. MATERIALS AND METHODS 
2.1. Genetic manipulation, mutagenesis and DNA sequencing 
The 1.65 kbp fragment containing the gene encoding p- 
hydroxybenzoate hydroxylase from P. fluorescens [1 11 was subjected 
to site-directed mutagenesis n the bacteriophage Ml3mp18 according 
to the method of Kunkel [12]. E. co/i JM109 [13] was used for 
methylation of phage DNA. Uracil containing single-stranded DNA 
was generated in E. coli RZ1032 [12] 
The mutagenic oligonucleotide 5 ‘-GCGAAGCC~GGCGCC- 
AC-3’ (Cl 16S, 10 pmol) was annealed to 1 pg single-stranded DNA 
and extended using 250aM of each of the dNTPs, 5 mM DTT, 10 mM 
Tris-HCl, pH 8.0, 10 mM MgClz and 1.5 U Klenow DNA polymerase 
1 in a final volume of 20~1 for 2 h at 16°C. After addition of 1~1 10 
mM ATP and 1 U T4 DNA-ligase the incubation was continued for 
3 h at 16°C. E. co/i TG2 was transformed with the reaction mixture 
and single-stranded DNA was isolated. 
Screening for mutants was performed by sequencing the region 
where the mutation was expected using an oligonucleotide (bp 
318-334) as sequencing primer. Clones carrying the mutation were 
then sequenced entirely to screen for undesired mutations using the 
universal sequencing primer and 6 oligonucleotides (His-22, 
bpl20-136; Leu-88, bp 318-334; Asp-159, bp 530-546; Val-231, bp 
748-763; Gly-298, bp 948-964; Glu-367, bp 1154-1171). 
From a positive clone double-stranded DNA was isolated and 
digested with Hind111 and EcoRl. The resulting 1.65 kbp insert was 
then ligated into pUC9 (pAW46), transformed in E. coli TG2 and 
resulting clones were screened for production of p-hydroxybenzoate 
hydroxylase. 
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2.2. Purification of enzymes 
Wild-type and mutant (Cl 16s) p-hydroxybenzoate hydroxylase 
were purified from E. coli TG2 transformed with the appropriate x- 
pression plasmid as described in [ 111. 
2.3. Analytical methods 
SDS-PAGE was carried out in 12.5% polyacrylamide slab gels [2]. 
Analytical gel filtration (Superose 12) and analytical anionic exchange 
chromatography (Mono Q) were performed using FPLC equipment, 
essentially as described in [2]. 
2.4. Chemical modification of sulfhydryl groups 
Labeling of wild-type and mutant enzyme with 5,5’-dithiobis(2- 
nitrobenzoate) (Ellman’s reagent) under non-denaturing conditions 
was carried out as described earlier [2,4]. 
Chemical modification of wild-type and mutant enzyme by Hz02 
was performed at pH 8.0 as reported in [2]. 
2.5 Crystal structure analysis 
Crystals of the mutant (Cl 16s) p-hydroxybenzoate hydroxylase 
were obtained by the free interface diffusion method as described by 
Van der Laan et al. [3]: 5 ,uI of a solution containing 10 mg/ml pro- 
tein, 10 mM p-hydroxybenzoate, 0.3 mM EDTA, 30 mM sodium 
sulphite were layered on top of 5 pl of a 65% saturated ammonium 
sulfate solution in 50 mM phosphate buffer (pH 7.5). The 
temperature was gradually increased from 4°C to 20°C in 3 weeks. 
Diffraction data were collected on a FAST area detector and pro- 
cessed by the MADNES program package [ 141. 
3. RESULTS 
3. I Biochemical properties of mutant p-hydroxy- 
benzoate hydroxylase 
The mutant (Cl 16s) p-hydroxybenzoate hydroxylase 
was purified from extracts of E. coli TG2 cells overex- 
pressing the protein from the plasmid vector pAW46. 
The yield of mutant enzyme was comparable to that of 
wild-type enzyme, overexpressed in this host [l 11. In 
contrast to wild-type enzyme [l 11, the mutant protein 
eluted from the preparative DEAE anion-exchanger in 
one symmetrical peak. When subjected to SDS-PAGE, 
the mutant enzyme migrated as a single band with an 
apparent M, of about 43 000, identical to the value 
found for fully Cys-116 reduced wild-type enzyme [ 111. 
Gel filtration through Superose 12 in the absence of 
dithiothreitol clearly showed that both wild-type and 
mutant enzyme migrated as dimers. No higher-order 
quaternary structures, as found under nonreducing 
purification conditions [3,4], were detectable. 
The specific activity of the C116S mutant (50 
Uemg-‘) compared favourably with the value obtained 
for the wild-type enzyme [ll], confirming previous 
results from chemical modification studies [4,15]. 
3.2 Chemical modification of sulfhydryl groups 
p-Hydroxybenzoate hydroxylase from P. jluorescens 
contains 5 sulfhydryl groups [2], but only Cys- 116 is ac- 
cessible to 5,5 ‘-dithiobis(2-nitrobenzoate) and N- 
ethylmaleimide [141. 
Both wild-type and mutant enzyme were analyzed for 
their sulfhydryl content under nondenaturing condi- 
tions. In contrast to wild-type enzyme (about 1.1 mol 
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Fig. 1. Chemical modification of wild-type and Cl 16s mutant p- 
hydroxybenzoate hydroxylase by hydrogen peroxide as monitored by 
FPLC analysis (Mono Q column). (A) Chromatogram of wild-type 
enzyme. (B) Chromatogram of wild-type enzyme after 120 min reac- 
tion time. (C) Chromatogram of Cl 16s mutant. (D) Chromatogram 
of Cl 16s mutant after 120 min reaction time. 
SH/mol FAD) the Cl 16s mutant showed almost no 
reactivity (less than 0.1 mol SH/mol FAD) with 
Ellman’s reagent. 
After chemical modification of p-hydroxybenzoate 
hydroxylase from P. fluorescens by Hz02 , at least 6 ap- 
parently different forms of enzyme molecules could be 
separated by ultrathin isoelectric focusing and/or 
anionic exchange chromatography [2]. It was suggested 
that the different products of oxidation represent 
(hybrid) forms of dimeric enzyme containing sulfenic, 
sulfinic and sulfonic acid derivatives of Cys-116. 
We now have repeated the oxidation experiments 
with both wild-type and mutant enzyme. From Fig. 1D 
it is clear that even after 120 min of incubation in the 
presence of excess Hz02 the C 116s mutant eluted in one 
symmetrical peak, showing the same retention time as 
the reference sample (Fig. 1C). In contrast, in the wild- 
type enzyme Cys-116 was almost completely converted 
to the sulfonic acid state (Fig. 1B). 
3.3. Structure determination 
Crystals of the mutant (Cl 16s) p-hydroxybenzoate 
hydroxylase grew to a maximum size of 0.2x0.5 x0.8 
mm3 in a period of 40 days. They appear to be isomor- 
phous to those of wild-type protein [3] having space 
group C2221 and cell dimensions a = 71.5 A, b = 145.8 
A, and c= 88.2 A. A total of 59 381 intensities were col- 
lected which yielded to 25 172 independent reflections 
(F > c~) with R,,, = 3.5% (Rsym=C (I-Iav( /XI,,). 
This corresponds to 91% of all the possible reflections 
between 100 A and 2.1 A. 
A difference Fourier map calculated with coefficients 
IFnative - (Fc116sI and model phases [6] had the highest 
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Fig. 2. The peak in the difference IFnative - IFc,16sI Fourier map at 
the position of the side chain of Cys-116. Due to the replacement of 
the cysteine residue also a water molecule (OHH 505) changes its posi- 
tion. The map is contoured at 50 level. 
peak (2 times higher than the second one) at the position 
of Syll6 (Fig. 2). This suggests that no other significant 
differences, except from those due to the replacement 
of the cysteine residue, are present in the structure of 
the mutated enzyme. 
4. DISCUSSION 
In p-hydroxybenzoate hydroxylase from P. 
fluorescens the Cys-116 residue is part of a surface loop 
connecting helix H6 and P-strand A3, and is situated 
about 2.5 nm away from the active site [3,6]. In the 
absence of reducing agents, Cys-116 is slowly oxidized 
in air yielding either sulfenyl derivatives or an inter- 
molecular disulfide bond [2,3]. The fully reduced state 
of Cys-116 was shown to be essential in order to obtain 
high quality crystals [3]. 
The mutation of Cys-116 to a serine residue has now 
been shown to generate a p-hydroxybenzoate hydrox- 
ylase no longer sensitive towards oxidation causing 
microheterogeneity and aggregation. Chemical modifi- 
cation by Hz02 and Ellman’s reagent was completely 
blocked in the Cl 16s mutant. Replacement of the cys- 
teine residue by an uncharged residue did not influence 
the crystal packing. 
The mutated (C116S) gene is an attractive starting 
frame for further modification studies with one restric- 
tion. The reactivity of Cys-116 allowed covalently bin- 
ding of the enzyme to Sepharose 5,5’-dithiobis(2- 
nitrobenzoate) [16]. In this way it was possible to 
prepare large amounts of highly stable apoprotein, a 
prerequisite for NMR studies on 13C- and i5N-FAD 
reconstituted enzymes [17]. Therefore, for preparation 
of mutant apoenzymes, the presence of Cys-116 is ad- 
vantageous. 
Acknowledgements: We gratefully acknowledge the support of Dr 
H.A. Schreuder regarding the crystallographic experiments. This 
research was supported in part by the Netherlands Foundation of 
Chemical Research (S.O.N.) with financial aid from the Netherlands 
Organization for Scientific Research (N.W.O.). 
REFERENCES 
[ll 
PI 
[31 
141 
151 
161 
171 
181 
PI 
[lOI 
1111 
1121 
iI31 
1141 
[I51 
1161 
[I71 
Sadana, A. and Malhotra, A. (1987) Biotechnol. Bioeng. 30, 
1041-1056. 
Van Berkel, W.J.H. and Miiller, F. (1987) Eur. J. Biochem. 167, 
35-46. 
Van der Laan, J.M., Swarte , M.B.A., Groendijk, H., HOI, 
W.G.J. and Drenth, J. (1989) Eur. J. Biochem. 179, 715-724. 
Mtiller, F., Voordouw, G., Van Berkel, W.J.H., Steennis, P.J., 
Visser, S. and Van Rooijen, P. (1979) Eur. J. Biochem. 101, 
235-244. 
Husain, M. and Massey, V. (1979) J. Biol. Chem. 254, 
6657-6666. 
Schreuder, H.A., Prick, P., Wierenga, R.K., Vriend, G., 
Wilson, K.S., HOI, W.G.J. and Drenth, J. (1989) J. Mol. Biol. 
208, 679-696. 
Van Berkel, W.J.H. and Miiller, F. (1989) Eur. J. Biochem. 179, 
307-314. 
Entsch, B. and Ballou, D.P. (1989) Biochim. Biophys. Acta 999, 
313-322. 
Van Berkel, W.J.H., Miiller, F., Jekel, P.J., Weijer, W., 
Schreuder, H.A. and Wierenga, R.K. (1988) Eur. J. Biochem. 
176, 449-459. 
Entsch, B., Nan, Y., Weaich, K. and Scott, K.F. (1988) Gene 71, 
279-291. 
Westphal, A.H., Van Berkel, W.J.H., Benen, J.A.E., Van 
Dongen, W.M.A.M. and De Kok, A. (1990) FEBS Lett., sub- 
mitted. 
Kunkel, T.A., Roberts, J.D. and Zakour, R.A. (1987) Methods 
Enzymol. 154, 367-382. 
Yanish-Perron, C., Viera, J. and Messing, J. (1985) Gene 33, 
103-l 19. 
Pflugrath, J.W. and Messerschmidt, A. (1986) MADNES User’s 
GUIDE, Max-Planck-Institut fur Biochemie, Martinsried, Ger- 
many. 
Van Berkel, W.J.H., Weijer, W.J., Miiller, F., Jekel, P.A. and 
Beintema, J.J. (1984) Eur. J. B&hem. 145, 245-256. 
Van Berkel, W.J.H. and Miiller, F. (1982) Eur. J. Biochem. 128, 
21-27. 
Vervoort, J.J.M., Van Berkel, W.J.H., Moonen, C.T.W. and 
Miiller, F. (1990) Eur. J. Biochem. (submitted). 
199 
